Genetic factors influencing age at onset in LRRK2-linked Parkinson disease

Parkinsonism and Related Disorders

Volumn 15, Issue 7, 2009, Pages 539-541

  Golub, Yulia ^a,f   Berg, Daniela ^a   Calne, Donald B ^b   Pfeiffer, Ronald F ^c   Uitti, Ryan J ^d   Stoessl, A Jon ^b   Wszolek, Zbigniew K ^d   Farrer, Matthew J ^d   Mueller, Jakob C ^a,e   Gasser, Thomas ^a   Fuchs, Julia ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d MAYO CLINIC   (United States)

^e MAX PLANCK INSTITUTE FOR ORNITHOLOGY   (Germany)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

AAO; LRRK2; MAPT; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2; RAS PROTEIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FAMILY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HEREDITY; HETEROZYGOTE; HUMAN; MALE; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67650725747     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.10.008     Document Type: Article

References (12)

1. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
2. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der B.M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
3. Giasson B.I., and Van Deerlin V.M. Mutations in LRRK2 as a cause of Parkinson's disease. Neurosignals 16 (2008) 99-105
4. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7 (2006) 306-318
5. Skipper L., Wilkes K., Toft M., Baker M., Lincoln S., Hulihan M., et al. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 75 (2004) 669-677
6. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 56 (2004) 591-595
7. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 57 (2005) 535-541
8. Wszolek Z.K., Pfeiffer B., Fulgham J.R., Parisi J.E., Thompson B.M., Uitti R.J., et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 45 (1995) 502-505
9. Zimprich A., Muller-Myhsok B., Farrer M., Leitner P., Sharma M., Hulihan M., et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 74 (2004) 11-19
10. Berg D., Schweitzer K., Leitner P., Zimprich A., Lichtner P., Belcredi P., et al. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*. Brain 128 (2005) 3000-3011
11. Tan E.K. Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. Ann Acad Med Singapore 35 (2006) 840-842
12. Rajput A., Dickson D.W., Robinson C.A., Ross O.A., Dachsel J.C., Lincoln S.J., et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67 (2006) 1506-1508